Phase 2 follow-up results of the BHT-3009 DNA vaccine for multiple sclerosis

Havrdova, E ; Krasulova, E ; Nadj, C G ; Selmaj, K ; Losy, J ; Nadj, I ; Radue, E-W ; Gianettoni, J ; Valone, F ; Utz, P J ; Robinson, W H ; Steinman, L ; Garren, H

Multiple sclerosis, 2008-09, Vol.14, p.S47-S47 [Periódico revisado por pares]

Texto completo disponível